The basic understanding of pediatric heart failure and its treatments is lacking. Experts have identified research gaps that should be prioritized over the next decade.Read More
Mortality from sickle cell disease peaks in patients in their 30s. A smoother transition from pediatric to adult care may help address it.
In patients receiving bone marrow transplant for Fanconi anemia, overall survival is nearly 20% higher for those treated since 2008, shows a recent study.
Haploidentical bone marrow transplantation may help increase the donor pool for patients with sickle cell disease. A recent study reports two-year event-free survival comparable to matched sibling donor myeloablative transplant.
Three pediatric gastroenterologists discuss advances in their diagnostic and interventional toolkits for esophageal dysfunction.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Results from two early-phase trials suggest that CRISPR/CASP 12 gene editing has the potential to cure sickle cell disease and transfusion-dependent beta-thalassemia.
Cleveland Clinic Children’s Center for Artificial Intelligence (C4AI) is developing innovative technology and algorithms to help care for patients with congenital heart disease. Early projects include predicting cardiac arrest, kidney injury and low cardiac output syndrome after surgery.
Patients with hypertrophic cardiomyopathy who do vigorous exercise are no more likely to experience a life-threatening arrhythmia than those who do only moderate or sedentary activity, says a prospective study.
Vaping weakens the epithelial barrier in airways, shows a new study. RSV infection doubles in bronchial cells exposed to e-cigarette nicotine.
Long-term quality of life among congenital heart disease survivors may have more to do with neurodevelopmental, psychosocial and physical factors than surgical and ICU-related variables.
The use of fetal echocardiography to guide management of congenital heart disease in a setting of multidisciplinary care optimizes neonatal outcomes, according to Cleveland Clinic fetal cardiologist Rashmi Rao, MD.